Phytoestrogenic Composition for Menopausal Symptom Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional hormone replacement therapies for menopause symptoms, such as Premarin, have severe adverse effects including increased cancer incidence, heart disease, and stroke, necessitating the development of safer alternatives.
Innovation Solution
A pharmaceutical and food composition containing cinnamic acid and shanzhiside methylester, which exhibit synergistic phytoestrogenic activity, are used to alleviate menopausal symptoms by mimicking estrogen effects without the harmful side effects of synthetic estrogens.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional hormone replacement therapy (e.g., Premarin) is used to treat menopausal symptoms, then relief from symptoms is achieved, but the risk of cancer, heart disease, and stroke increases
Solution Approach 1:
The patent uses phytoestrogens (cinnamic acid and shanzhiside methylester) as intermediary substances that can mimic estrogen's beneficial effects on menopausal symptoms without triggering the harmful effects of conventional estrogen therapy. These phytoestrogens act as mediators between the need for hormone replacement and the risk of adverse events, providing therapeutic benefit with improved safety profile
Solution Approach 2:
The patent employs plant-derived phytoestrogens as alternative to long-term conventional estrogen therapy. These natural compounds provide transient but effective symptom relief without the cumulative harmful effects associated with prolonged synthetic estrogen use, particularly regarding cancer and cardiovascular risks
2Ease of operation
If synthetic estrogen is used for hormone replacement therapy, then menopausal symptoms are effectively treated, but severe adverse effects occur
Solution Approach 1:
The patent changes the chemical parameters by using plant-derived phytoestrogens (cinnamic acid and shanzhiside methylester) instead of synthetic estrogens. These natural compounds have different molecular structures and binding affinities that allow them to activate estrogen receptors for symptom relief while avoiding the harmful effects associated with synthetic estrogen structures
Solution Approach 2:
The patent uses a composite approach by combining two different phytoestrogen compounds (cinnamic acid and shanzhiside methylester) in specific ratios. This combination leverages the synergistic effects of different plant-derived estrogens to provide comprehensive symptom relief while maintaining a safer safety profile compared to single synthetic estrogen formulations
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively induces estrogen-specific ALP, providing relief from diverse menopausal symptoms like hot flashes, osteoporosis, and cardiovascular issues without the adverse effects associated with traditional hormone replacement therapies.
Implementation Method 1
cinnamic acid and shanzhiside methylester, which exhibit synergistic phytoestrogenic activity, are used to alleviate menopausal symptoms by mimicking estrogen effects
Implementation Method 2
The composition effectively induces estrogen-specific ALP, providing relief from diverse menopausal symptoms
Data Source
Figure 1
AI summary
The present invention relates to a pharmaceutical composition for preventing or treating a menopausal symptom, comprising cinnamic acid, shanzhiside methylester or a mixture thereof as an active ingredient. The composition of the present invention exhibits an excellent estrogenic activity, and is effectively utilized for treating or preventing diverse menopausal symptoms generated by estrogen deficiency during perimenopause, menopause and postmenopause.